Home›People›Howard Palefsky
HP

Howard Palefsky

Director at Dignify Therapeutics.

Director
Updated Nov 9, 2026·Latest SEC filing Sep 25, 2026·Suggest an edit

About Howard Palefsky

Howard Palefsky is a director at Dignify Therapeutics.

Experience

This experience comes from Howard Palefsky's profile and from SEC filings. For roles taken from filings, the years are when the filings name Howard Palefsky in the role, so the role may have started earlier or lasted longer.

Inpharmus Current
Member of the Board of Advisors
2026 – Present
Vita Strategic Advisory (vitastrategic.com) Current
Partner
2026 – Present
ONAR Holdings Current
Board Member
2025 – Present
Robbie.ai Current
Chairman of the Board
2025 – Present
Dignify Therapeutics, LLC Current
Director
2024 – Present · Research Triangle Park, NC
Develops bowel and bladder drugs for older adults and people with neurological conditions.
Franklin Biolabs Current
Board Member
2024 – Present
Bioculture Group Current
Board Member
2024 – Present
Georgia Research Alliance Current
Senior Advisor
2024 – Present
Silicon Valley Innovations Current
Board Member
2024 – Present
Covanos, Inc. Current
Board Member
2024 – Present
Victoria Capital Management Current
Investor, Board Member, Board Chair
2016 – Present
YPO Current
Former Chapter Chair, Northern California Chapter; Former Board Member, YPO International
1984 – Present
Predictiv Care 🧬
Board Member
2024 – 2026
Montreux Equity Partners
Managing Director
2002 – 2015
Howard Palefsky
Private Investor, Board Member, Board Chair,Interim CEO
1997 – 2002
Collagen Corporation
Chairman, President and CEO
1978 – 1997
ALZA CORPORATION DELAWARE (ALZA CORPORATION)
Vice President, Marketing
1973 – 1978
Whitehall Laboratories Division of American Home Products
Marketing Manager
1971 – 1972
Commissioned Corps of the U.S. Public Health Service
Lt.(jg)
1967 – 1969

Key Colleagues at Startups

The people Howard Palefsky works with at each company, as listed on that company's latest Form D.

Dignify Therapeutics, LLC · Form D, Sep 25, 2026
NK
Neil Kurtz
Director
Anthony DiTonno
Anthony DiTonno
CEO and director
Karl Thor
Karl Thor
Chief Scientific Officer and director
EG
Eric Green
Director
Edward Burgard
Edward Burgard
President and director

Sources

  1. SECDignify Therapeutics, LLC Form D, filed Sep 25, 2026